Stocks · Healthcare · Medical - Diagnostics & Research
Danaher Corporation DHR
$214.06 +1.09% Close, Oct 2, 2026 · NYSE · Market cap $150.48B
Next earnings report: Oct 21, 2026
Scroll or pinch to zoom, drag to move. Daily prices adjusted for splits. Markers: E = earnings (green beat, red miss), S = split, D = dividend.
Three things to know
- Earnings beat analyst estimates in each of the last 6 quarters (average surprise over the last four: +6.0%).
- Net debt is 3.1× EBITDA, a high level of leverage.
- Diluted EPS over the last four quarters was $5.63, up 19.8% year over year.
PromtFinance scores
Each score is a percentile within the Healthcare sector (0–100). Under each score: how the stock ranks in its sector on every component. As of Oct 5, 2026.
Growth41Weak
How fast revenue, earnings and cash flow are growing.
- Revenue growth (TTM, YoY)Bottom 39%
- EPS growth (TTM, YoY)Top 41%
- FCF growth (TTM, YoY)Top 47%
- Revenue growth, 3-year CAGRBottom 18%
- Revenue growth accelerationTop 40%
Quality78Positive
Returns on capital, margins, earnings quality and balance-sheet strength.
- Return on invested capitalTop 24%
- Gross marginBottom 44%
- Operating marginTop 13%
- Cash conversion (OCF / net income)Top 44%
- Accruals (lower is better)Bottom 29%
- Net debt / EBITDA (lower is better)Bottom 29%
- Interest coverTop 4%
Value66Positive
How cheap the shares are relative to earnings, cash flow and their own history.
- Earnings yieldTop 21%
- Free-cash-flow yieldTop 23%
- EBITDA / enterprise valueTop 26%
- Sales / enterprise valueBottom 38%
- P/E vs own 5-year history (lower is better)Bottom 33%
Momentum63Neutral
Strength and persistence of the price trend, including versus the S&P 500.
- 12-month return excluding last monthBottom 35%
- 6-month returnTop 46%
- 1-year return vs S&P 500Bottom 43%
- Distance from 52-week highTop 19%
- Trend checklist (0–4)Top 7%
Revisions48Neutral
Earnings surprises and analyst sentiment (estimate-revision history is being collected).
- Average EPS surprise, last 4 quartersTop 45%
- Consecutive EPS beatsTop 12%
- Share of analysts rating BuyBottom 38%
- Upside to consensus price targetBottom 15%
Stability75Positive
Low volatility, shallow drawdowns, low market sensitivity and modest leverage.
- Volatility, 60 days (lower is better)Top 20%
- Maximum drawdown, 3 yearsTop 16%
- Beta vs S&P 500 (lower is better)Top 35%
- Net debt / EBITDA (lower is better)Bottom 29%
What changed
Latest four quarters versus the same period a year earlier (growth: versus one quarter earlier).
| Measure | Before | Now | |
|---|---|---|---|
| Revenue growth (YoY) | 4.0% | 4.6% | ↑ |
| EPS growth (YoY) | 0.4% | 19.8% | ↑ |
| Gross margin | 61.5% | 58.5% | ↓ |
| Operating margin | 21.5% | 20.4% | ↓ |
| FCF margin | 20.2% | 21.8% | ↑ |
Fundamental momentum
| Measure | Now (TTM) | Year / quarter before | Sector rank | |
|---|---|---|---|---|
| Revenue growth (TTM, YoY) | 4.6% | 4.0% | ↑ | Bottom 39% |
| EPS growth (TTM, YoY) | 19.8% | 0.4% | ↑ | Top 41% |
| Gross margin | 58.5% | 61.5% | ↓ | Bottom 44% |
| Operating margin | 20.4% | 21.5% | ↓ | Top 13% |
| Net margin | 15.9% | 14.2% | ↑ | — |
| Free-cash-flow margin | 21.8% | 20.2% | ↑ | — |
| Return on invested capital | 5.0% | — | Top 24% | |
| Revenue growth, 3-year CAGR | -2.7% | — | Bottom 18% |
Quality of earnings and balance sheet
- Cash conversion (OCF / net income)Above 1× means profits are backed by cash.
- 1.66×
- Accruals (net income − OCF) / assetsLower is better; high accruals can signal weaker earnings quality.
- -2.8%
- Stock-based compensation / revenueA cost to shareholders through dilution.
- 1.5%
- Receivables growth vs revenue growthReceivables growing much faster than sales can be a warning.
- -16.8 pp
- Net debt / EBITDABelow 1× is conservative; above 3× is high leverage.
- 3.11×
- Interest cover (operating income / interest)How many times operating profit covers interest.
- 65.7×
Shareholder returns
- Dividend yield (dividends paid, TTM)
- 0.64%
- Net buyback yield (TTM)
- 1.94%
- Shareholder yield
- 2.58%
- Share count change, 1 year
- -1.6%
- Share count change, 3-year CAGR
- -1.7%
Shareholder yield = dividends + net buybacks over the last four quarters, divided by market cap.
Based on the four quarters through Jun 26, 2026 (filed Jul 21, 2026).
Earnings and expectations
Earnings momentum
- Consecutive EPS beats
- 6
- Beats in the last 8 reports
- 7 of 8
- Average EPS surprise, last 4
- +6.0%
- Average 2-day reaction, last 8
- -2.4%
- Positive 20 days after report
- 4 of 8
Analysts
- Consensus price target
- $227.62
- Target vs current price
- +6.3%
- Analysts with a rating
- 43
- Share rating Buy or Strong Buy
- 70%
- Consensus rating
- Buy
How the stock reacted to recent reports
| Report date | EPS surprise | 2 days | 5 days | 20 days | 60 days |
|---|---|---|---|---|---|
| Jul 21, 2026 | +4.9% | -11.0% | -2.3% | +0.8% | — |
| Apr 21, 2026 | +6.2% | -0.5% | -7.6% | -16.2% | +4.9% |
| Jan 28, 2026 | +3.2% | -4.8% | -8.1% | -11.1% | -24.3% |
| Oct 21, 2025 | +9.9% | +5.9% | +6.1% | +5.8% | +15.1% |
| Jul 22, 2025 | +9.8% | +1.0% | +7.9% | +11.1% | +9.6% |
| Apr 22, 2025 | +15.3% | +3.8% | +5.9% | +6.2% | +5.3% |
| Jan 29, 2025 | +0.0% | -9.7% | -13.2% | -15.5% | -20.7% |
| Oct 22, 2024 | +8.9% | -4.0% | -10.3% | -15.4% | -12.4% |
Returns from the close before each report. Past reactions do not determine future ones.
Earnings history
| Report date | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|
| Jul 21, 2026 | $1.94 | $1.85 | +4.9% | $6.26B |
| Apr 21, 2026 | $2.06 | $1.94 | +6.2% | $5.95B |
| Jan 28, 2026 | $2.23 | $2.16 | +3.2% | $6.84B |
| Oct 21, 2025 | $1.89 | $1.72 | +9.9% | $6.05B |
| Jul 22, 2025 | $1.80 | $1.64 | +9.8% | $5.94B |
| Apr 22, 2025 | $1.88 | $1.63 | +15.3% | $5.74B |
| Jan 29, 2025 | $2.14 | $2.14 | +0.0% | $6.54B |
| Oct 22, 2024 | $1.71 | $1.57 | +8.9% | $5.80B |
Valuation in context
| Multiple | Now | 5-year median | 5-year percentile | Sector rank (cheapness) |
|---|---|---|---|---|
| P/E (trailing) | 38.0× | 34.9× | 62th | Top 21% |
| P/E (forward) | 25.2× | — | — | — |
| EV / EBITDA | 24.1× | — | — | Top 26% |
| EV / Sales | 6.88× | — | — | Bottom 38% |
| Free-cash-flow yield | 3.63% | — | — | Top 23% |
| Earnings yield | 2.63% | — | — | Top 21% |
P/E over the past five years
Range 22.2× – 49.9× since Jul 2, 2021. Each point: price on the filing date divided by trailing-twelve-month EPS known then.
What moved the stock over the past year
- Price return, 1 year
- +0.6%
- Earnings per share growth (TTM)
- +19.8%
- Change in P/E multiple
- -21.3%
Most of the move came from a change in the valuation multiple.
Technical state
Trend checklist
- ✓ Price above 20-day average
- ✓ Price above 50-day average
- ✓ Price above 200-day average
- ✓ 50-day average above 200-day
- ✗ MACD histogram positive
Trend quality
- Days above the 50-day average
- 15
- Days above the 200-day average
- 15
- 50-day average slope (20 days)
- +3.7%
- 200-day average slope (20 days)
- -0.6%
- Distance from 50-day average
- +2.5%
- Distance from 200-day average
- +6.2%
- RSI (14)
- 50.0
- Relative volume
- 0.91×
Risk and drawdowns
- Volatility, 60 days (annualized)
- 38.7%
- Volatility vs own 5-year history
- 92th percentile · High for this stock
- Beta vs S&P 500 (2 years, weekly)
- 0.86
- Correlation with S&P 500
- 0.40
- Current drawdown from 1-year high
- -11.6%
- Maximum drawdown, 3 years
- -42.3%
Largest declines in the past six years
| From peak | To low | Decline | Length | Recovery |
|---|---|---|---|---|
| Sep 3, 2021 | May 15, 2026 | -45.1% | 1178 days | Not yet recovered |
| Feb 12, 2021 | Mar 8, 2021 | -13.6% | 15 days | 32 days (Apr 22, 2021) |
| Nov 6, 2020 | Nov 27, 2020 | -11.7% | 14 days | 52 days (Feb 12, 2021) |
Declines of 10% or more from a closing high, measured on daily closes.
Financial statements
- Market cap
- $150.48B
- P/E (TTM)
- 38.0
- EPS, diluted (TTM)
- $5.63
- Revenue (TTM)
- $25.11B
- Dividend yield
- 0.71%
- 52-week range
- $160.93 – $242.80
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Revenue | $29.45B | $26.64B | $23.89B | $23.88B | $24.57B |
| Gross profit | $17.95B | $16.19B | $14.03B | $14.21B | $14.97B |
| Operating income | $8.05B | $7.54B | $5.28B | $5.18B | $5.14B |
| Net income | $6.43B | $7.21B | $4.76B | $3.90B | $3.61B |
| EPS (diluted) | $8.61 | $9.64 | $6.38 | $5.29 | $5.04 |
| Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $5.80B | $6.54B | $5.74B | $5.94B | $6.05B | $6.84B | $5.95B | $6.26B |
| Net income | $818.0M | $1.09B | $954.0M | $555.0M | $908.0M | $1.20B | $1.03B | $870.0M |
| EPS (diluted) | $1.12 | $1.49 | $1.32 | $0.77 | $1.27 | $1.68 | $1.45 | $1.23 |
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Operating cash flow | $8.36B | $8.52B | $7.16B | $6.69B | $6.42B |
| Capital expenditure | -$1.29B | -$1.15B | -$1.38B | -$1.39B | -$1.16B |
| Free cash flow | $7.06B | $7.37B | $5.78B | $5.30B | $5.26B |
| Dividends paid | -$742.0M | -$818.0M | -$821.0M | -$768.0M | -$878.0M |
| Net share buybacks | $86.0M | $31.0M | $68.0M | -$5.82B | -$3.00B |
Cash outflows are shown as negative numbers.
- Cash and short-term investments
- $4.35B
- Total assets
- $92.37B
- Total liabilities
- $39.79B
- Total debt
- $26.56B
- Net debt
- $22.21B
- Shareholders’ equity
- $52.58B
As of Jun 26, 2026 (filed Jul 21, 2026).
Dividends
| Ex-date | Amount | Paid |
|---|---|---|
| Sep 30, 2026 | $0.40 | Oct 30, 2026 |
| Jun 26, 2026 | $0.40 | Jul 31, 2026 |
| Mar 27, 2026 | $0.40 | Apr 24, 2026 |
| Dec 26, 2025 | $0.32 | Jan 30, 2026 |
| Sep 26, 2025 | $0.32 | Oct 31, 2025 |
| Jun 27, 2025 | $0.32 | Jul 25, 2025 |
| Mar 28, 2025 | $0.32 | Apr 25, 2025 |
| Dec 27, 2024 | $0.27 | Jan 31, 2025 |
Short interest
- Shares sold short
- 8,344,032
- Days to cover
- 2.69
- Change vs previous report
- -13.4%
FINRA short interest, settlement date Sep 15, 2026.
Stock splits
- Oct 2, 2023
- 141-for-125
- Jul 5, 2016
- 1,319-for-1,000
- Jun 14, 2010
- 2-for-1
- May 21, 2004
- 2-for-1
- Jun 1, 1998
- 2-for-1